Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Multi-cohort Evaluation of [18F]CSB-321 PET Imaging in Participants Receiving Immunotherapy for the Treatment of Cancer

NCT07057349 is registered in ClinicalTrials.gov with Cytosite Biopharma Inc. as lead sponsor.

NCT NCT07057349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07057349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Multi-cohort Evaluation of [18F]CSB-321 PET Imaging in Participants Receiving Immunotherapy for the Treatment of Cancer
Lead sponsor
Cytosite Biopharma Inc.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
February 28, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, unresectable solid tumor